NEW YORK–(BUSINESS WIRE)– #A–To all persons and entities that purchased or otherwise acquired publicly traded Instadose Pharma Corp. (“Instadose”) securities from July 14, 2021, through November 24, 2021, both dates inclusive (collectively, the “Class”, and individually “Class Members”). YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an order of the United States District Court for the Eastern District of Virginia (the “Court”), that you may be a member o
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://mmpconnect.com/summary-notice-of-pendency-of-class-action/?utm_source=rss&utm_medium=rss&utm_campaign=summary-notice-of-pendency-of-class-action
